Cargando…

Use of Autologous Blood Components in Lymphedema Treatment: A Systematic Review

The main benefit of autologous therapies is its easier obtention and relatively lower concerns regarding ethical implications and patient safety. We conducted a systematic review of publications assessing the potential use of blood components (lymphocytes, red blood cells (RBCs), platelet-rich plasm...

Descripción completa

Detalles Bibliográficos
Autores principales: Forte, Antonio J, Boczar, Daniel, Huayllani, Maria T, Bagaria, Sanjay, McLaughlin, Sarah A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822891/
https://www.ncbi.nlm.nih.gov/pubmed/31700741
http://dx.doi.org/10.7759/cureus.5638